← Leaderboards
Kyle Fink
University Of California At Davis
$1,827,422
Attributed
$3,502,587
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $630.2K · FY2014–25$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,502,587 · 4
By mechanism
R01$3,350,331 · 1
F32$102,256 · 1
R13$50,000 · 2
Top collaborators
- Jan A. Nolta7 shared
Most similar at University Of California At Davis
Same institution · by research overlap
- Frank R Sharp$27,056,128
Others in their field
Top investigators on “Neurodegenerative Disorders”
- Adam L Boxer · Mayo Clinic Rochester$61,054,677
- Paul S. Aisen · Cognition Therapeutics, Inc.$56,063,985
- Ronald C Petersen · Mayo Clinic Coll Of Medicine, Rochester$55,774,157
- Reisa A. Sperling · Banner Health$50,784,577
- Jane S Paulsen · University Of Wisconsin-Madison$38,012,377
- John Q. Trojanowski · University Of Pennsylvania$37,152,274
Research focus
Neurodegenerative DisordersBrainHuntington DiseaseClinical TrialsGene TherapyFundingProteinsVectorNeurogenesisNeuronsNovel TherapeuticsTechnologyLaboratoriesFutureAdultMissionAreaNervous System DisorderCellsNational Institute Of Neurological Disorders And StrokeCellular EngineeringAllelesCell TherapyAnimal Data
Grant awards (11)
MSCS ENGINEERED TO PRODUCE BDNF AND GENE EDITING CARGO FOR THE TREATMENT OF HUNTINGTON'S DISEASE$346,046
R01 · FY2025 · NS · contact PI
MSCS ENGINEERED TO PRODUCE BDNF AND GENE EDITING CARGO FOR THE TREATMENT OF HUNTINGTON'S DISEASE$377,253
R01 · FY2024 · NS · contact PI
MSCS ENGINEERED TO PRODUCE BDNF AND GENE EDITING CARGO FOR THE TREATMENT OF HUNTINGTON'S DISEASE$388,921
R01 · FY2023 · NS · contact PI
MSCS ENGINEERED TO PRODUCE BDNF AND GENE EDITING CARGO FOR THE TREATMENT OF HUNTINGTON'S DISEASE$388,921
R01 · FY2022 · NS · contact PI
2020 American Society for Neural Therapy and Repair Conference$25,000
R13 · FY2020 · NS · contact PI
MSCs engineered to produce Brain-Derived Neurotrophic Factor for the Treatment of Huntington's disease$597,167
R01 · FY2019 · NS
2019 AMERICAN SOCIETY FOR NEURAL THERAPY AND REPAIR$25,000
R13 · FY2019 · NS · contact PI
MSCs engineered to produce Brain-Derived Neurotrophic Factor for the Treatment of Huntington's disease$621,833
R01 · FY2018 · NS
MSCs engineered to produce Brain-Derived Neurotrophic Factor for the Treatment of Huntington's disease$630,190
R01 · FY2017 · NS
Novel epigenetic targets for silencing the Huntingtons disease mutation$52,406
F32 · FY2015 · NS · contact PI
Novel epigenetic targets for silencing the Huntingtons disease mutation$49,850
F32 · FY2014 · NS · contact PI